E
VolitionRx Limited
VNRX
$0.566
-$0.024-4.07%
E
Sell
2/24/2025Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 2/24/2025 due to a decline in the volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 2/24/2025 due to a decline in the volatility index.
D
Sell
2/6/2025Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 2/6/2025 due to an increase in the volatility index, total return index and growth index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 2/6/2025 due to an increase in the volatility index, total return index and growth index.
E
Sell
1/21/2025Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 1/21/2025 due to a decline in the volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 1/21/2025 due to a decline in the volatility index.
D
Sell
1/6/2025Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 1/6/2025 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0845 to -$0.0662, operating cash flow increased 19.97% from -$6.73M to -$5.39M, and total revenue increased 19.88% from $395.8 to $474.5.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 1/6/2025 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0845 to -$0.0662, operating cash flow increased 19.97% from -$6.73M to -$5.39M, and total revenue increased 19.88% from $395.8 to $474.5.
E
Sell
10/24/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 10/24/2024 due to a decline in the volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 10/24/2024 due to a decline in the volatility index.
D
Sell
10/9/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 10/9/2024 due to an increase in the volatility index and total return index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 10/9/2024 due to an increase in the volatility index and total return index.
E
Sell
9/20/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 9/20/2024 due to a decline in the volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 9/20/2024 due to a decline in the volatility index.
D
Sell
9/4/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 9/4/2024 due to an increase in the volatility index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 9/4/2024 due to an increase in the volatility index.
E
Sell
8/19/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 8/19/2024 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.38 to 0.2, and debt to equity increased from -0.31 to -0.24.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 8/19/2024 due to a decline in the solvency index, volatility index and total return index. The quick ratio declined from 0.38 to 0.2, and debt to equity increased from -0.31 to -0.24.
D
Sell
8/15/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 8/15/2024 due to an increase in the volatility index and valuation index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 8/15/2024 due to an increase in the volatility index and valuation index.
E
Sell
7/24/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 7/24/2024 due to a decline in the volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 7/24/2024 due to a decline in the volatility index.
D
Sell
7/9/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 7/9/2024 due to an increase in the volatility index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 7/9/2024 due to an increase in the volatility index.
E
Sell
6/20/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 6/20/2024 due to a decline in the volatility index and total return index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 6/20/2024 due to a decline in the volatility index and total return index.
D
Sell
5/31/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 5/31/2024 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.1095 to -$0.1021, and EBIT increased 4.07% from -$8.74M to -$8.38M.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 5/31/2024 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.1095 to -$0.1021, and EBIT increased 4.07% from -$8.74M to -$8.38M.
E
Sell
5/14/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 5/14/2024 due to a decline in the volatility index and total return index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 5/14/2024 due to a decline in the volatility index and total return index.
D
Sell
4/29/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
E
Sell
4/12/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 4/12/2024 due to a decline in the volatility index.
D
Sell
3/27/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 3/27/2024 due to an increase in the volatility index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 3/27/2024 due to an increase in the volatility index.
E
Sell
3/25/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 3/25/2024 due to a decline in the volatility index and total return index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 3/25/2024 due to a decline in the volatility index and total return index.
D
Sell
3/8/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 3/8/2024 due to an increase in the volatility index and total return index.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 3/8/2024 due to an increase in the volatility index and total return index.
E
Sell
2/22/2024Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 2/22/2024 due to a decline in the volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 2/22/2024 due to a decline in the volatility index.
D
Sell
2/6/2024Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 2/6/2024 due to an increase in the growth index and valuation index. Earnings per share increased from -$0.1416 to -$0.11, and EBIT increased 9.38% from -$9.55M to -$8.65M.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 2/6/2024 due to an increase in the growth index and valuation index. Earnings per share increased from -$0.1416 to -$0.11, and EBIT increased 9.38% from -$9.55M to -$8.65M.
E
Sell
8/15/2023Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 8/15/2023 due to a decline in the valuation index and total return index.
VolitionRx Limited (VNRX) was downgraded to E+ from D- on 8/15/2023 due to a decline in the valuation index and total return index.
D
Sell
3/16/2023Upgraded
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 3/16/2023 due to an increase in the valuation index and growth index. Total revenue increased 266.06% from $32.7 to $119.7, operating cash flow increased 23.99% from -$6.82M to -$5.18M, and earnings per share increased from -$0.138 to -$0.1258.
VolitionRx Limited (VNRX) was upgraded to D- from E+ on 3/16/2023 due to an increase in the valuation index and growth index. Total revenue increased 266.06% from $32.7 to $119.7, operating cash flow increased 23.99% from -$6.82M to -$5.18M, and earnings per share increased from -$0.138 to -$0.1258.
E
Sell
3/14/2023Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index and valuation index.
VolitionRx Limited (VNRX) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index and valuation index.
D
Sell
2/23/2023Upgraded
VolitionRx Limited (VNRX) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
VolitionRx Limited (VNRX) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
D
Sell
2/8/2023Downgrade
VolitionRx Limited (VNRX) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
VolitionRx Limited (VNRX) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
12/13/2022Upgraded
VolitionRx Limited (VNRX) was upgraded to D from D- on 12/13/2022 due to an increase in the growth index. Earnings per share increased from -$0.1422 to -$0.138, and EBIT increased 1.31% from -$8.1M to -$7.99M.
VolitionRx Limited (VNRX) was upgraded to D from D- on 12/13/2022 due to an increase in the growth index. Earnings per share increased from -$0.1422 to -$0.138, and EBIT increased 1.31% from -$8.1M to -$7.99M.
D
Sell
8/15/2022Downgrade
VolitionRx Limited (VNRX) was downgraded to D- from D on 8/15/2022 due to a large decline in the growth index, total return index and solvency index. Operating cash flow declined 309.56% from $2.99M to -$6.27M, debt to equity increased from 0.33 to 0.7, and total revenue declined 65.15% from $114.2 to $39.8.
VolitionRx Limited (VNRX) was downgraded to D- from D on 8/15/2022 due to a large decline in the growth index, total return index and solvency index. Operating cash flow declined 309.56% from $2.99M to -$6.27M, debt to equity increased from 0.33 to 0.7, and total revenue declined 65.15% from $114.2 to $39.8.
D
Sell
5/16/2022Upgraded
VolitionRx Limited (VNRX) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
VolitionRx Limited (VNRX) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.18 to 0.33, and the quick ratio declined from 3.16 to 1.36.
VolitionRx Limited (VNRX) was downgraded to E+ from D on 5/13/2022 due to a decline in the solvency index, total return index and volatility index. Debt to equity increased from 0.18 to 0.33, and the quick ratio declined from 3.16 to 1.36.
D
Sell
5/4/2022Upgraded
VolitionRx Limited (VNRX) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
VolitionRx Limited (VNRX) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
VolitionRx Limited (VNRX) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
D
Sell
4/21/2022Upgraded
VolitionRx Limited (VNRX) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
VolitionRx Limited (VNRX) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
VolitionRx Limited (VNRX) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.14 to 0.18, and the quick ratio declined from 3.92 to 3.16.
VolitionRx Limited (VNRX) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.14 to 0.18, and the quick ratio declined from 3.92 to 3.16.
D
Sell
11/11/2021Upgraded
VolitionRx Limited (VNRX) was upgraded to D from D- on 11/11/2021 due to an increase in the total return index.
VolitionRx Limited (VNRX) was upgraded to D from D- on 11/11/2021 due to an increase in the total return index.
D
Sell
11/8/2021Downgrade
VolitionRx Limited (VNRX) was downgraded to D- from D on 11/8/2021 due to a decline in the total return index, solvency index and growth index. Debt to equity increased from 0.11 to 0.12, the quick ratio declined from 5.51 to 5.17, and total revenue declined 2.75% from $25.5 to $24.8.
VolitionRx Limited (VNRX) was downgraded to D- from D on 11/8/2021 due to a decline in the total return index, solvency index and growth index. Debt to equity increased from 0.11 to 0.12, the quick ratio declined from 5.51 to 5.17, and total revenue declined 2.75% from $25.5 to $24.8.
D
Sell
5/1/2020Upgraded
VolitionRx Limited (VNRX) was upgraded to D from D- on 5/1/2020 due to a substantial increase in the growth index. Operating cash flow increased 30.11% from -$3.72M to -$2.6M, earnings per share increased from -$0.1048 to -$0.0865, and EBIT increased 10.8% from -$4.18M to -$3.73M.
VolitionRx Limited (VNRX) was upgraded to D from D- on 5/1/2020 due to a substantial increase in the growth index. Operating cash flow increased 30.11% from -$3.72M to -$2.6M, earnings per share increased from -$0.1048 to -$0.0865, and EBIT increased 10.8% from -$4.18M to -$3.73M.
D
Sell
5/12/2017Downgrade
VolitionRx Limited (VNRX) was downgraded to D- from D on 5/12/2017 due to a decline in the efficiency index, growth index and total return index. Operating cash flow declined 13.28% from -$2.36M to -$2.67M, earnings per share declined from -$0.1149 to -$0.13, and net income declined 12.29% from -$2.98M to -$3.35M.
VolitionRx Limited (VNRX) was downgraded to D- from D on 5/12/2017 due to a decline in the efficiency index, growth index and total return index. Operating cash flow declined 13.28% from -$2.36M to -$2.67M, earnings per share declined from -$0.1149 to -$0.13, and net income declined 12.29% from -$2.98M to -$3.35M.
D
Sell
3/10/2017Upgraded
VolitionRx Limited (VNRX) was upgraded to D from D- on 3/10/2017 due to an increase in the volatility index, efficiency index and total return index. Total capital increased 86.58% from $12.14M to $22.65M, and net income increased 14.23% from -$3.48M to -$2.98M.
VolitionRx Limited (VNRX) was upgraded to D from D- on 3/10/2017 due to an increase in the volatility index, efficiency index and total return index. Total capital increased 86.58% from $12.14M to $22.65M, and net income increased 14.23% from -$3.48M to -$2.98M.
D
Sell
8/8/2016Downgrade
VolitionRX Ltd (VNRX) was downgraded to D- from D on 8/8/2016 due to a significant decline in the volatility index, total return index and efficiency index.
VolitionRX Ltd (VNRX) was downgraded to D- from D on 8/8/2016 due to a significant decline in the volatility index, total return index and efficiency index.
D
Sell
11/5/2015Downgrade
VolitionRX Ltd (VNRX) was downgraded to D from D+ on 11/5/2015 due to a decline in the efficiency index, solvency index and valuation index. Total capital declined 24.64% from $10.02M to $7.55M, and the quick ratio declined from 7.3 to 6.31.
VolitionRX Ltd (VNRX) was downgraded to D from D+ on 11/5/2015 due to a decline in the efficiency index, solvency index and valuation index. Total capital declined 24.64% from $10.02M to $7.55M, and the quick ratio declined from 7.3 to 6.31.
D
Sell
10/1/2015Upgraded
VolitionRX Ltd (VNRX) was upgraded to D+ from D on 10/1/2015 due to a major increase in the volatility index.
VolitionRX Ltd (VNRX) was upgraded to D+ from D on 10/1/2015 due to a major increase in the volatility index.
D
Sell
8/12/2015Upgraded
VolitionRX Ltd (VNRX) was upgraded to D from D- on 8/12/2015 due to a large increase in the solvency index, efficiency index and growth index.
VolitionRX Ltd (VNRX) was upgraded to D from D- on 8/12/2015 due to a large increase in the solvency index, efficiency index and growth index.
D
Sell
7/7/2015Downgrade
VolitionRX Ltd (VNRX) was downgraded to D- from D on 7/7/2015 due to a significant decline in the volatility index and valuation index.
VolitionRX Ltd (VNRX) was downgraded to D- from D on 7/7/2015 due to a significant decline in the volatility index and valuation index.
D
Sell
5/13/2015Downgrade
VolitionRX Ltd (VNRX) was downgraded to D from D+ on 5/13/2015 due to a substantial decline in the total return index and growth index.
VolitionRX Ltd (VNRX) was downgraded to D from D+ on 5/13/2015 due to a substantial decline in the total return index and growth index.
D
Sell
3/19/2015Downgrade
VolitionRX Ltd (VNRX) was downgraded to D+ from C- on 3/19/2015 due to a significant decline in the efficiency index, valuation index and total return index. Total capital declined 108.98% from -$4.1M to $368.2, and net income declined 84.02% from -$5.89M to -$942.
VolitionRX Ltd (VNRX) was downgraded to D+ from C- on 3/19/2015 due to a significant decline in the efficiency index, valuation index and total return index. Total capital declined 108.98% from -$4.1M to $368.2, and net income declined 84.02% from -$5.89M to -$942.
C
Hold
2/12/2015None
VolitionRx Limited (VNRX) was downgraded to C- from U on 02/12/2015.
VolitionRx Limited (VNRX) was downgraded to C- from U on 02/12/2015.
AMEX
03/12/2025 4:00PM Eastern
Quotes delayed
